Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.
Katz
M H
MH
San Francisco Department of Public Health, CA 94102-6033, USA.
Gerberding
J L
JL
D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006291:Health Policy; D006801:Humans; D008297:Male; D011322:Primary Prevention; D012725:Sexual Behavior; D015819:Substance Abuse, Intravenous; D014481:United States; D015215:Zidovudine / Q000191:economics / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine